Skip to main content
Top
Published in: Clinical & Experimental Metastasis 7/2009

Open Access 01-10-2009 | Research Paper

Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma

Authors: Jennifer L. Dembinski, Stefan Krauss

Published in: Clinical & Experimental Metastasis | Issue 7/2009

Login to get access

Abstract

Evidence suggests that multiple tumors, including pancreatic adenocarcinoma, display heterogeneity in parameters that are critical for tumor formation, progression and metastasis. Understanding heterogeneity in solid tumors is increasingly providing a plethora of new diagnostic and therapeutic approaches. In this study, a particular focus was put on identifying a subpopulation of stem cell-like, slow cycling tumor cells in a pancreas adenocarcinoma cell lines. Using a label retention technique a subpopulation of slow cycling cells (DiI+/SCC) was identified and further evaluated in the BxPC-3 and Panc03.27 cell lines. These slowly cycling cells managed to retain the lipophilic labeling dye DiI, while the bulk of the cells (>94%) did not. The DiI+/SCC population, showed only a partial overlap with the CSC markers CD24+/CD44+, CD133+ and ALDH but they survived chemotherapeutic treatment, and were able to recreate the initial heterogeneous tumor cell population. DiI+/SCCs exhibited an increased invasive potential as compared with their non-label retaining, faster cycling cells (DiI−/FCC). They also had increased tumorigenic potential and morphological changes resembling cells that have undergone an epithelial to mesenchymal transition (EMT). Analysis of DiI+/SCC cells by real time PCR revealed a selective up-regulation of tell tale components of the Hedgehog/TGFβ pathways, as well as a down-regulation of EGFR, combined with a shift in crucial components implied in EMT. The presented findings offer an expanded mechanistic understanding that associates tumor initiating potential with cycling speed and EMT in pancreatic cancer cell lines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hoyert DL, Heron MP, Murphy SL et al (2006) Deaths: final data for 2003. Nat Vital Stat Rep 54:1–120 Hoyert DL, Heron MP, Murphy SL et al (2006) Deaths: final data for 2003. Nat Vital Stat Rep 54:1–120
10.
go back to reference Bailey JM, Singh PK, Hollingsworth MA (2007) Cancer metastasis facilitated by developmental pathways: sonic hedgehog, notch, and bone morphogenic proteins. J Cell Biochem 102:829–839. doi:10.1002/jcb.21509 CrossRefPubMed Bailey JM, Singh PK, Hollingsworth MA (2007) Cancer metastasis facilitated by developmental pathways: sonic hedgehog, notch, and bone morphogenic proteins. J Cell Biochem 102:829–839. doi:10.​1002/​jcb.​21509 CrossRefPubMed
14.
go back to reference Costello RT, Mallet F, Gaugler B et al (2000) Human acute myeloid leukemia CD34+/. Cancer Res 60:4403–4411PubMed Costello RT, Mallet F, Gaugler B et al (2000) Human acute myeloid leukemia CD34+/. Cancer Res 60:4403–4411PubMed
19.
go back to reference Verfaillie CM, Miller JS (1995) A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC. Blood 86:2137–2145PubMed Verfaillie CM, Miller JS (1995) A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC. Blood 86:2137–2145PubMed
21.
go back to reference Fairley EA, Riddell A, Ellis JA et al (2002) The cell cycle dependent mislocalisation of emerin may contribute to the Emery-Dreifuss muscular dystrophy phenotype. J Cell Sci 115:341–354PubMed Fairley EA, Riddell A, Ellis JA et al (2002) The cell cycle dependent mislocalisation of emerin may contribute to the Emery-Dreifuss muscular dystrophy phenotype. J Cell Sci 115:341–354PubMed
22.
go back to reference Batard P, Monier MN, Fortunel N et al (2000) TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 113(Pt 3):383–390PubMed Batard P, Monier MN, Fortunel N et al (2000) TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 113(Pt 3):383–390PubMed
23.
go back to reference Huang S, Law P, Francis K et al (1999) Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. Blood 94:2595–2604PubMed Huang S, Law P, Francis K et al (1999) Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. Blood 94:2595–2604PubMed
31.
32.
go back to reference Frankel A, Rosen K, Filmus J et al (2001) Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L). Cancer Res 61:4837–4841PubMed Frankel A, Rosen K, Filmus J et al (2001) Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L). Cancer Res 61:4837–4841PubMed
33.
go back to reference Dembinski J, Spaeth E, Sasser K et al (2009) Mesenchymal stem cell (MSC) edification; tumor microenvironment drives MSC differentation into tumor-associated fibroblasts that contribute to fibrovascular network expansion. PLoS ONE 4(4):e4992. doi:10.1371/journal.pone.0004992 CrossRefPubMed Dembinski J, Spaeth E, Sasser K et al (2009) Mesenchymal stem cell (MSC) edification; tumor microenvironment drives MSC differentation into tumor-associated fibroblasts that contribute to fibrovascular network expansion. PLoS ONE 4(4):e4992. doi:10.​1371/​journal.​pone.​0004992 CrossRefPubMed
34.
36.
go back to reference Zemskova M, Sahakian E, Bashkirova S et al (2008) The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. J Biol Chem 283:20635–20644. doi:10.1074/jbc.M709479200 CrossRefPubMed Zemskova M, Sahakian E, Bashkirova S et al (2008) The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. J Biol Chem 283:20635–20644. doi:10.​1074/​jbc.​M709479200 CrossRefPubMed
38.
39.
go back to reference Krishnamurthy K, Wang G, Rokhfeld D et al (2008) Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide. Breast Cancer Res 10:R106. doi:10.1186/bcr2211 CrossRefPubMed Krishnamurthy K, Wang G, Rokhfeld D et al (2008) Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide. Breast Cancer Res 10:R106. doi:10.​1186/​bcr2211 CrossRefPubMed
Metadata
Title
Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma
Authors
Jennifer L. Dembinski
Stefan Krauss
Publication date
01-10-2009
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 7/2009
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-009-9260-0

Other articles of this Issue 7/2009

Clinical & Experimental Metastasis 7/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine